Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis
Mauricio Cordero-Alfaro; Carlos León-Céspedes; Allan Ramos-Esquivel;
Reumatol Clin. 2021;17:329-34
Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis
Tomás Miranda-Aquino; Diego Alejandro Ramos-Aguas; Silvia Esmeralda Pérez-Topete; María del Socorro Cepeda-Rocha; Xochitl Citlalli Gómez-Gómez; Daniel Ochoa-Castillo; Sergio Cerpa-Cruz; Verónica González-Díaz; Christian González-Padilla; Jorge Eduardo Hernández-del Río;
10.1016/j.reumae.2025.501841
Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: data from the BIOBADAGUAY registry
Paloma de Abreu; Sonia Cabrera; Darwin Cordovilla; Lourdes Román; Cristina Brunengo; Patricia Melgarejo; Macarena Soto; Vannia Valinotti; Angelica Amarilla; Belem Acevedo; Alexis Pineda; Evelyn Leiva; Paola Pusineri; Sandra Consani; Mariela Zarza; Clyde Parodi; Zoilo Morel; Roger Rolón; Paola Jara; Raquel Aranda; Laura Martínez; Gabriela Ávila;
Reumatol Clin. 2025;21: